IP Library Granted Patent US 12,551,384
Granted Patent B2
US 12,551,384 · App. 18/267,982 · Granted Feb 17, 2026

Disposable wearing article and method for manufacturing the same

Inventor: Akiko Nagano (Ehime, JP)
Assignee: Daio Paper Corporation
A61F13/51113A61F13/15577A61F2013/51117
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,551,384
App. No.
18/267,982
Granted
Feb 17, 2026
Kind
B2
Abstract

A disposable wearing article having an excellent rash preventing effect. The above problem is solved by a disposable wearing article including a top sheet having a skin contact region in contact with a skin of a wearer, wherein the skin contact region has, in a region to which a body fluid pervious treatment agent containing a nonionic surfactant having an amide group is applied, a glycerin-containing region to which glycerin is applied, and the top sheet has a two-layer structure of an upper layer of less than 2.0 dtex and a lower layer of 2.0 to 4.0 dtex, and is formed of a nonwoven fabric having a basis weight of 5 to 40 g/m 2 .

Claims (18)

1 . A disposable wearing article comprising

a top sheet having a skin contact region configured to contact a skin of a wearer,

wherein the top sheet has a two-layer structure of an upper layer of a fineness of 1.0 to 1.7 dtex and a lower layer of a fineness of 2.1 to 3.3 dtex, a basis weight of the top sheet is 15 to 25 g/m2, and the top sheet is a hydrophilic nonwoven fabric applying a hydrophilizing agent,

wherein the skin contact region has,

in a region in which a body fluid pervious treatment agent is attached, the body fluid pervious treatment agent comprising a nonionic surfactant consisting of a single fatty acid alkanolamide having an HLB value of 9.5 to 14, and the body fluid pervious treatment agent not containing an anionic surfactant, a cationic surfactant, or an amphoteric ion-based surfactant,

a glycerin-containing region to which a hydrophilic lotion containing 70 to 90% by weight of glycerin and 10 to 30% by weight of water is applied, and

an attachment amount of the body fluid pervious treatment agent in the region in which the body fluid pervious treatment agent is attached is 0.05 to 2% by weight on the basis of a fiber weight of the top sheet,

the glycerin-containing region in the region in which the body fluid pervious treatment agent is attached, contains 0.7 to 2.7 g/m 2 of glycerin and has a size of 100 mm or more in an MD (Machine Direction) direction and a size of 5 mm or more in a CD (Cross Direction) direction, and

an area ratio of the glycerin-containing region in the skin contact region in an unfolded state is 3% or more.

2 . The disposable wearing article according to claim 1 , comprising:

the top sheet; a second sheet; and an absorbent element in this order,

wherein the second sheet is formed of an air through nonwoven fabric, and at least a surface of the second sheet in contact with the top sheet has a fineness of 4.0 to 6.0 dtex and a total thickness of 0.3 to 1.3 mm, and the body fluid pervious treatment agent is applied to the second sheet.

3 . A method for manufacturing a disposable wearing article including a top sheet having a skin contact region configured to contact a skin of a wearer, comprising:

using, as the top sheet, a hydrophilic nonwoven fabric having a two-layer structure of an upper layer of a fineness of 1.0 to 1.7 dtex and a lower layer of a fineness of 2.1 to 3.3 dtex, and having a basis weight of 15 to 25 g/m 2 ;

attaching a body fluid pervious treatment agent to the nonwoven fabric, the body fluid pervious treatment agent containing a nonionic surfactant consisting only of a single fatty acid alkanolamide having an HLB value of 9.5 to 14 as a nonionic surfactant, and the body fluid pervious treatment agent not containing an anionic surfactant, a cationic surfactant, or an amphoteric ion-based surfactant,

forming a region attaching the body fluid pervious treatment agent in which an attachment amount of the body fluid pervious treatment agent is 0.05 to 2% by weight on the basis of a fiber weight;

applying a hydrophilic lotion containing 70 to 90% by weight of glycerin and 10 to 30% by weight of water, to the region attaching the body fluid pervious treatment agent; and

forming a glycerin-containing region containing 0.7 to 2.7 g/m2 of glycerin and having a size of 100 mm or more in an MD (Machine Direction) direction, a size of 5 mm or more in a CD (Cross Direction) direction, and an area ratio of the glycerin-containing region in the skin contact region in an unfolded state of 3% or more.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2023
From: NAGANO, AKIKO
To: DAIO PAPER CORPORATION
Reel/Frame 065467/0713 →
Priority Claims (1)
JP 2021-048150 · Mar 23, 2021 · national
Continuity (1)
Related Publication 20240033137A1 · Feb 1, 2024
References Cited (33)
US 6166285A · Schulte · 2000 [cited by applicant]
US 8138387B2 · Vega · 2012 [cited by examiner]
US 8481480B1 · Lam · 2013 [cited by examiner]
US 8637728B2 · Fingal · 2014 [cited by examiner]
US 10517982B2 · Vega · 2019 [cited by examiner]
US 11045362B2 · Guidotti · 2021 [cited by examiner]
US 20040158216A1 · Kasai · 2004 [cited by examiner]
US 20050059941A1 · Baldwin · 2005 [cited by examiner]
US 20080249491A1 · Young · 2008 [cited by applicant]
US 20080287903A1 · Vega et al. · 2008 [cited by applicant]
US 20180221220A1 · Kuramochi · 2018 [cited by applicant]
US 20210059873A1 · Fujikawa · 2021 [cited by applicant]
EP 4159173A1 · 2023 [cited by applicant]
EP 4190290A1 · 2023 [cited by applicant]
JP 2004166832A · 2004 [cited by applicant]
JP 2010526630 · 2010 [cited by applicant]
JP 2013059517 · 2013 [cited by applicant]
JP 2014068942 · 2014 [cited by applicant]
JP 2015066290 · 2015 [cited by applicant]
JP 2018083064A · 2018 [cited by applicant]
JP 2018178331 · 2018 [cited by applicant]
JP 2019002122 · 2019 [cited by applicant]
JP 2020031922A · 2020 [cited by applicant]
JP 2020031923A · 2020 [cited by applicant]
JP 2020174996A · 2020 [cited by applicant]
TW 201446946A · 2014 [cited by applicant]
TW 201818893A · 2018 [cited by applicant]
TW 202009018A · 2020 [cited by applicant]
WO 2013038965A1 · 2013 [cited by applicant]
WO 2020044968A1 · 2020 [cited by applicant]
International Search Report and the Written Opinion for PCT/JP2022/005965, dated Jun. 16, 2023. [cited by applicant]
Extended European Search Report for EP Patent Application No. 22774775.5, dated Feb. 11, 2025. [cited by applicant]
Office Action for TW Appl. No. 111105177A, dated Jun. 23, 2025. [cited by applicant]